We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Danish Quality Assurance Project on Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (COPD) in Outpatient Lung Clinics

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00268866
First Posted: December 23, 2005
Last Update Posted: April 16, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Boehringer Ingelheim
  Purpose
Danish Quality Assurance Project on Diagnosis and Treatment of COPD in Outpatient Lung Clinics

Condition Intervention Phase
Pulmonary Disease, Chronic Obstructive Behavioral: Education Phase 4

Study Type: Observational
Official Title: Danish Quality Assurance Project on Diagnosis and Treatment of COPD in Outpatient Lung Clinics

Resource links provided by NLM:


Further study details as provided by Boehringer Ingelheim:

Primary Outcome Measures:
  • To optimise the diagnosis and treatment of COPD via a quality assurance project
  • Increase the knowledge and use of diagnostic tools and treatment options
  • Increase focus on COPD comorbidity

Estimated Enrollment: 1820
Estimated Study Completion Date: January 2007
Detailed Description:

Study Hypothesis:

Comparison(s):

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   35 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Outpatient with the diagnosis or referral diagnosis of COPD.
  • COPD must be the primary reason for this outpatient contact (for both new patients and controls).

Exclusion Criteria:

  • Any co-morbidity that hampers the diagnosis and treatment of COPD in accordance with the COPD guidelines used locally (e.g. malignant disease, dementia or sequelae of apoplexy).
  • Asthma without the presence of COPD
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00268866


Sponsors and Collaborators
Boehringer Ingelheim
Investigators
Study Chair: Boehringer Ingelheim Study Coordinator B.I. Denmark A/S
  More Information

ClinicalTrials.gov Identifier: NCT00268866     History of Changes
Other Study ID Numbers: 205.367
First Submitted: December 22, 2005
First Posted: December 23, 2005
Last Update Posted: April 16, 2008
Last Verified: April 2008

Additional relevant MeSH terms:
Lung Diseases
Pulmonary Disease, Chronic Obstructive
Chronic Disease
Respiratory Tract Diseases
Lung Diseases, Obstructive
Disease Attributes
Pathologic Processes


To Top